Association between Fecal Calprotectin and Mucosal Healing in Pediatric Patients with Crohn's Disease Who Have Achieved Sustained Clinical Remission with Anti-Tumor Necrosis Factor Agents

CONCLUSIONS: FC was associated with MH in pediatric patients with CD who had achieved a sustained CR for at least 6 months with anti-TNF agents. In these patients, FC can be used to stratify patients and guide decisions regarding ileocolonoscopy in the treat-to-target era.PMID:33833135 | DOI:10.5009/gnl20300

Source: Gut and Liver - April 9, 2021 Category: Gastroenterology Authors: Yoo Min Lee Sujin Choi Byung-Ho Choe Hyo-Jeong Jang Seung Kim Hong Koh Eun Sil Kim Mi Jin Kim Yon Ho Choe Ben Kang Source Type: research